查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1453970

到 2030 年重建皮肤模型的全球市场预测：按类型、应用、最终用户和地区进行分析

Reconstructed Skin Models Market Forecasts to 2030 - Global Analysis By Type, By Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球重建皮肤模型市场规模为 3,740 万美元，预计到 2030 年将达到 9,970 万美元，预测期内复合年增长率为 15.0%。

重建皮肤模型是实验室製造的结构，模仿人类皮肤的特性和功能。这些模型通常由生长在支架或基质上的细胞层组成，复製表皮、真皮，有时会复製皮下层。它用于製药、化妆品和医学研究，以研究皮肤生理学、毒性测试以及护肤产品和治疗方法的有效性。

根据美国皮肤病学会2022年发布的统计数据，美国每天约有9500人被诊断出患有皮肤癌。

对动物试验替代品的需求不断增长

重建皮肤模型提供了一种人道且符合道德的测试方法，取代了动物测试的需要。此外，它密切模仿人体皮肤生理和对各种物质的反应，从而产生更准确和可靠的结果。随着对动物测试的监管更加严格以及动物福利意识的提高，重建皮肤模型的采用预计将显着增加。

开发和检验成本高

创建准确可靠的皮肤模型需要先进的实验室设施、专业设备和熟练的人员，并且需要大量的投资。此外，进行严格的检验研究以确保模型准确地再现人类皮肤生理学也会增加成本。这些成本对于小型研究机构和公司来说是昂贵的，并且可能限制重建皮肤模型的开发和采用。此外，漫长而复杂的检验过程可能会延迟新模型的商业化，并阻碍其普及和市场成长。

组织工程技术进步

细胞培养技术、生物材料和 3D 列印技术的创新使得更复杂和生理相关的皮肤模型的开发成为可能。这些进步使研究人员能够创建具有更高准确性、功能性和可重复性的模型，以更好地模拟人类皮肤生理学和病理学。此外，自动化和高通量筛检技术的进步正在促进重建皮肤模型的快速且经济高效的生产和检验，从而推动市场成长。

缺乏标准化

缺乏普遍接受的模型开发、检验和使用通讯协定和指南，导致实验室和研究之间的模型品质、性能和再现性存在差异。这种差异破坏了研究结果的可靠性和可比性，并阻碍了皮肤重建模型在监管测试和工业应用中的采用。此外，如果没有标准化的方法，就存在资料不一致和误解的风险，从而在相关人员中造成不确定性和怀疑。

COVID-19 的影响：

COVID-19 大流行扰乱了研究活动和供应链，从而影响了重建皮肤模型市场。实验室关闭、旅行限制和社交距离措施导致模型开发和检验研究的延迟。此外，分配给非新冠病毒相关研究的资金和资源减少进一步减缓了市场进展。然而，这种流行病也凸显了替代测试方法的重要性，这可能会推动未来对重建皮肤模型的需求。

预计预测期内化妆品检测领域规模最大

由于动物测试法规的不断加强以及消费者对无残忍和安全化妆品的需求不断增长，预计化妆品测试行业将在预测期内引领皮肤重建模型市场。重建皮肤模型提供了一种可靠的替代方案来评估化妆品的安全性、功效和毒性，而无需进行动物测试。此外，建模技术的进步以及道德和永续实践意识的提高进一步支持了皮肤重建模型在化妆品测试中的采用。

受託研究机构（CRO）部门预计在预测期内将呈现最高的复合年增长率。

受託研究机构（CRO）部门预计将在预测期内实现重建皮肤模型市场的最高成长率。这一成长是由製药、化妆品和医疗设备公司越来越多地将研究和测试活动外包给 CRO 所推动的。这些组织专门从事临床前研究，包括使用重建皮肤模型进行安全性和功效研究，为产品开发和法规遵循提供经济高效的解决方案。

比例最高的地区：

在预测期内，由于医疗保健和製药行业的强劲以及研发活动的频繁，北美地区预计将引领重建皮肤模型市场。该地区有严格的监管标准，推动了对可靠、准确的测试方法（例如重组皮肤模型）的需求。此外，人们越来越认识到化妆品和药品的道德和有效测试方法的重要性也有助于北美市场的成长。

复合年增长率最高的地区：

预计在预测期内，欧洲重组皮肤模型市场将显着成长。欧洲拥有完善的製药和化妆品行业，以及优先考虑安全性和功效测试的严格监管标准。此外，不断增加的研发投资以及人们对重建皮肤模型在道德和准确测试方面的好处的认识不断提高，正在推动该地区的市场成长。这些因素使欧洲成为重建皮肤模型的主要成长市场。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球重建皮肤模型市场：按类型

  • 表皮皮肤模型
  • 真皮模型
  • 3D重建皮肤模型

第六章全球重建皮肤模型市场：依应用分类

  • 化妆品检测
    • 皮肤刺激测试
    • 皮肤致敏试验
  • 化学和毒性测试
  • 其他用途

第七章全球重建皮肤模型市场：依最终用户分类

  • 合约研究组织（CRO）
  • 化妆品公司
  • 製药和生物技术公司
  • 研究机构和学术界
  • 其他最终用户

第八章全球重建皮肤模型市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • AIVITA Biomedical
  • Biopredic International
  • CellSystems
  • CellTechMed GmbH
  • Genoskin
  • LabSkin Creations
  • L'Oreal SA
  • MatTek Corporation
  • OrSkin
  • QGel SA
  • SkinEthic Laboratories
  • StratiCELL
  • Tissue Regeneration Sciences, Inc.
  • VITROCELL Systems GmbH
Product Code: SMRC25522

According to Stratistics MRC, the Global Reconstructed Skin Models Market is accounted for $37.4 million in 2023 and is expected to reach $99.7 million by 2030 growing at a CAGR of 15.0% during the forecast period. Reconstructed skin models are laboratory-produced structures that mimic the properties and functions of human skin. These models typically consist of layers of cells grown on scaffolds or matrices, replicating the epidermis, dermis, and sometimes the subcutaneous layer. They are used in pharmaceutical, cosmetic, and medical research to study skin physiology, toxicity testing, and the efficacy of skincare products and treatments.

According to 2022 statistics published by American Academy of Dermatology, it was reported that approximately 9,500 people are diagnosed with skin cancer every day in the U.S.

Market Dynamics:

Driver:

Growing demand for alternatives to animal testing

Reconstructed skin models offer a humane and ethical approach to testing, replacing the need for animal experimentation. Additionally, they provide more accurate and reliable results, as they closely mimic human skin physiology and response to various substances. With increasing regulatory restrictions on animal testing and rising awareness of animal welfare concerns, the adoption of reconstructed skin models is expected to rise significantly.

Restraint:

High cost of development and validation

Creating accurate and reliable skin models requires sophisticated laboratory facilities, specialized equipment, and skilled personnel, which entail substantial investments. Additionally, conducting rigorous validation studies to ensure the models accurately replicate human skin physiology further adds to the cost. These expenses can be prohibitive for smaller research institutions and companies, limiting their ability to develop and adopt reconstructed skin models. Moreover, the lengthy and complex validation process may delay the commercialization of new models, hindering their widespread adoption and market growth.

Opportunity:

Technological advancements in tissue engineering

Innovations in cell culture techniques, biomaterials, and 3D printing technologies enable the development of more sophisticated and physiologically relevant skin models. These advancements allow researchers to create models with improved accuracy, functionality, and reproducibility, better mimicking human skin physiology and pathology. Additionally, advancements in automation and high-throughput screening techniques facilitate the rapid and cost-effective generation and validation of reconstructed skin models, driving market growth.

Threat:

Lack of standardization

The absence of universally accepted protocols and guidelines for model development, validation, and usage results in variability in model quality, performance, and reproducibility across different laboratories and research studies. This inconsistency undermines the reliability and comparability of research findings, hindering the adoption of reconstructed skin models in regulatory testing and industrial applications. Moreover, without standardized methodologies, there is a risk of data discrepancies and misinterpretation, leading to uncertainty and skepticism among stakeholders.

Covid-19 Impact:

The COVID-19 pandemic has impacted the reconstructed skin models market by disrupting research activities and supply chains. Laboratory closures, travel restrictions, and social distancing measures have led to delays in model development and validation studies. Additionally, reduced funding and resources allocated to non-COVID-related research have further slowed progress in the market. However, the pandemic has also highlighted the importance of alternative testing methods, potentially driving future demand for reconstructed skin models.

The cosmetics testing segment is expected to be the largest during the forecast period

The cosmetics testing segment is projected to lead the reconstructed skin models market during the forecast period due to increasing regulatory restrictions on animal testing and rising consumer demand for cruelty-free and safe cosmetic products. Reconstructed skin models offer a reliable alternative for assessing the safety, efficacy, and toxicity of cosmetics without the need for animal testing. Additionally, advancements in model technology and growing awareness of ethical and sustainable practices further drive the adoption of reconstructed skin models in cosmetics testing.

The contract research organizations (CROs) segment is expected to have the highest CAGR during the forecast period

The contract research organizations (CROs) segment is anticipated to achieve the highest growth rate in the reconstructed skin models market during the forecast period. This growth can be attributed to the increasing outsourcing of research and testing activities by pharmaceutical, cosmetic, and medical device companies to CROs. These organizations specialize in conducting preclinical studies, including safety and efficacy testing using reconstructed skin models, offering cost-effective and efficient solutions for product development and regulatory compliance.

Region with largest share:

During the forecast period, the North American region is poised to lead the reconstructive skin models market owing to its robust healthcare and pharmaceutical industries and high levels of research and development activities. The region has stringent regulatory standards, driving the demand for reliable and accurate testing methods such as reconstructed skin models. Additionally, increasing awareness about the importance of ethical and effective testing methods for cosmetic and pharmaceutical products further contributes to the market's growth in North America.

Region with highest CAGR:

During the forecast period, Europe is expected to experience significant growth in the reconstructive skin models market. Europe boasts a well-established pharmaceutical and cosmetic industry, coupled with stringent regulatory standards that prioritize safety and efficacy testing. Additionally, increasing investments in research and development, along with growing awareness about the benefits of reconstructed skin models for ethical and accurate testing, are driving market growth in the region. These factors position Europe as a key growth market for reconstructive skin models.

Key players in the market

Some of the key players in Reconstructed Skin Models Market include AIVITA Biomedical, Biopredic International, CellSystems, CellTechMed GmbH, Genoskin, LabSkin Creations, L'Oreal S.A. , MatTek Corporation, OrSkin, QGel SA, SkinEthic Laboratories, StratiCELL, Tissue Regeneration Sciences, Inc. and VITROCELL Systems GmbH.

Key Developments:

In June 2023, L'Oreal announced a partnership with the University of California (UC) Berkeley's biotech incubator Bakar Labs. The collaboration opens up avenues for Bakar Labs' incubated startups to benefit from and gain access to L'Oreal's 3D reconstructed skin models, at no cost.

In March 2023, Chanel Research has just made a strategic leap forward to accelerate its knowledge of skin pigment spots, a major aesthetic concern among aging populations, particularly in Asia. In partnership with LabSkin Creations, the luxury giant has successfully used 3D bioprinting techniques to create reconstructed human skin on which a dark spot can appear.

Types Covered:

  • Epidermal Skin Models
  • Dermal Skin Models
  • 3D Reconstructed Skin Models

Applications Covered:

  • Cosmetics Testing
  • Chemicals and Toxicology Testing
  • Other Applications

End Users Covered:

  • Contract Research Organizations (CROs)
  • Cosmetic Companies
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes and Academia
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Reconstructed Skin Models Market, By Type

  • 5.1 Introduction
  • 5.2 Epidermal Skin Models
  • 5.3 Dermal Skin Models
  • 5.4 3D Reconstructed Skin Models

6 Global Reconstructed Skin Models Market, By Application

  • 6.1 Introduction
  • 6.2 Cosmetics Testing
    • 6.2.1 Skin Irritation Test
    • 6.2.2 Skin Sensitization Test
  • 6.3 Chemicals and Toxicology Testing
  • 6.4 Other Applications

7 Global Reconstructed Skin Models Market, By End User

  • 7.1 Introduction
  • 7.2 Contract Research Organizations (CROs)
  • 7.3 Cosmetic Companies
  • 7.4 Pharmaceutical and Biotechnology Companies
  • 7.5 Research Institutes and Academia
  • 7.6 Other End Users

8 Global Reconstructed Skin Models Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 AIVITA Biomedical
  • 10.2 Biopredic International
  • 10.3 CellSystems
  • 10.4 CellTechMed GmbH
  • 10.5 Genoskin
  • 10.6 LabSkin Creations
  • 10.7 L'Oreal S.A.
  • 10.8 MatTek Corporation
  • 10.9 OrSkin
  • 10.10 QGel SA
  • 10.11 SkinEthic Laboratories
  • 10.12 StratiCELL
  • 10.13 Tissue Regeneration Sciences, Inc.
  • 10.14 VITROCELL Systems GmbH

List of Tables

  • Table 1 Global Reconstructed Skin Models Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 4 Global Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 5 Global Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 6 Global Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 7 Global Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 8 Global Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 9 Global Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 10 Global Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 11 Global Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 12 Global Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 13 Global Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 14 Global Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 15 Global Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 16 Global Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 17 Global Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 20 North America Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 21 North America Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 22 North America Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 23 North America Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 24 North America Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 25 North America Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 26 North America Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 27 North America Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 28 North America Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 North America Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 North America Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 31 North America Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 32 North America Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 33 North America Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 34 North America Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 37 Europe Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 38 Europe Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 39 Europe Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 40 Europe Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 Europe Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 42 Europe Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 43 Europe Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 44 Europe Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 45 Europe Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 46 Europe Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 47 Europe Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 48 Europe Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 49 Europe Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 50 Europe Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 51 Europe Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 55 Asia Pacific Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 56 Asia Pacific Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 57 Asia Pacific Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 58 Asia Pacific Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 59 Asia Pacific Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 60 Asia Pacific Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 61 Asia Pacific Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 62 Asia Pacific Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 63 Asia Pacific Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 64 Asia Pacific Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 65 Asia Pacific Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 66 Asia Pacific Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 67 Asia Pacific Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 68 Asia Pacific Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 71 South America Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 72 South America Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 73 South America Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 74 South America Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 75 South America Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 76 South America Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 77 South America Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 78 South America Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 79 South America Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 80 South America Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 81 South America Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 82 South America Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 83 South America Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 84 South America Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 85 South America Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa Reconstructed Skin Models Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Reconstructed Skin Models Market Outlook, By Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Reconstructed Skin Models Market Outlook, By Epidermal Skin Models (2021-2030) ($MN)
  • Table 89 Middle East & Africa Reconstructed Skin Models Market Outlook, By Dermal Skin Models (2021-2030) ($MN)
  • Table 90 Middle East & Africa Reconstructed Skin Models Market Outlook, By 3D Reconstructed Skin Models (2021-2030) ($MN)
  • Table 91 Middle East & Africa Reconstructed Skin Models Market Outlook, By Application (2021-2030) ($MN)
  • Table 92 Middle East & Africa Reconstructed Skin Models Market Outlook, By Cosmetics Testing (2021-2030) ($MN)
  • Table 93 Middle East & Africa Reconstructed Skin Models Market Outlook, By Skin Irritation Test (2021-2030) ($MN)
  • Table 94 Middle East & Africa Reconstructed Skin Models Market Outlook, By Skin Sensitization Test (2021-2030) ($MN)
  • Table 95 Middle East & Africa Reconstructed Skin Models Market Outlook, By Chemicals and Toxicology Testing (2021-2030) ($MN)
  • Table 96 Middle East & Africa Reconstructed Skin Models Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 Middle East & Africa Reconstructed Skin Models Market Outlook, By End User (2021-2030) ($MN)
  • Table 98 Middle East & Africa Reconstructed Skin Models Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
  • Table 99 Middle East & Africa Reconstructed Skin Models Market Outlook, By Cosmetic Companies (2021-2030) ($MN)
  • Table 100 Middle East & Africa Reconstructed Skin Models Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 101 Middle East & Africa Reconstructed Skin Models Market Outlook, By Research Institutes and Academia (2021-2030) ($MN)
  • Table 102 Middle East & Africa Reconstructed Skin Models Market Outlook, By Other End Users (2021-2030) ($MN)